Andrea Palloni

6PUBLICATIONS
35CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 24, 2026
Prognostic Impact of Concomitant Genomic Alterations in FGFR2-Positive Cholangiocarcinoma Treated With Pemigatinib.

|Dec 30, 2025
Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives.

Martina Astore, Laura Fabbri, Andrea Monte

|Jun 13, 2025
Mutant p53 Associates with Human Equilibrative Nucleoside 1 Upregulation and Better Response to Adjuvant Gemcitabine in Intrahepatic Cholangiocarcinoma Patients.

Marzia Deserti, Valeria Relli, Andrea Palloni

|Jul 14, 2023
Improvements in Systemic Therapies for Advanced Malignant Mesothelioma.

Chiara Deiana, Francesca Fabbri, Simona Tavolari

|May 26, 2023
The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma.

Andrea Palloni, Silvia Bisello, Ilaria Maggio

|Aug 06, 2021
Hacking Pancreatic Cancer: Present and Future of Personalized Medicine.

Alessandro Di Federico, Valentina Tateo, Claudia Parisi

Pageof 1

Frequent Collaborators

3 joint publications

Giorgio Frega

3 joint publications

Alessandro Rizzo

2 joint publications

Chiara Deiana

2 joint publications

Simona Tavolari